WoundReference improves clinical decisions
 Choose the role that best describes you

Allogeneic matrix

Allogeneic matrix

Allogeneic matrix

OVERVIEW

Allogeneic Matrices are usually derived from human neonatal fibroblasts of the foreskin that may contain metabolically active or regenerative components primarily used for soft tissue support, though some have been approved for the treatment of full-thickness skin and soft tissue loss. Most are biodegradable and disappear after 3-4 weeks implantation. [1] This category also includes cellular and/or tissue products (also known as skin substitutes) derived from amnion, chorion, placenta or umbilical cord that have not been decellularized. 

Official reprint from WoundReference® woundreference.com ©2018 Wound Reference, Inc. All Rights Reserved
Use of WoundReference is subject to the Subscription and License Agreement. ​
NOTE: This is a controlled document. This document is not a substitute for proper training, experience, and exercising of professional judgment. While every effort has been made to ensure the accuracy of the contents, neither the authors nor the Wound Reference, Inc. give any guarantee as to the accuracy of the information contained in them nor accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omissions in the contents of the work.

REFERENCES

  1. Administrators, CGS et al. Local Coverage Determination (LCD) - Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities (L36690) . Date of publication 2016;.
Topic 18 Version 1.0

SUBTOPICS